Anexelekto/MER tyrosine kinase inhibitor ONO-7475 arrests growth and kills FMS-like tyrosine kinase 3-internal tandem duplication mutant acute myeloid leukemia cells by diverse mechanisms

Nearly one-third of patients with acute myeloid leukemia have FMS-like tyrosine kinase 3 mutations and thus have poor survival prospects. Receptor tyrosine kinase anexelekto is critical for FMS-like tyrosine kinase 3 signaling and participates in FMS-like tyrosine kinase 3 inhibitor resistance mecha...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruvolo, Peter P., Ma, Huaxian, Ruvolo, Vivian R., Zhang, Xiaorui, Mu, Hong, Schober, Wendy, Hernandez, Ivonne, Gallardo, Miguel, Khoury, Joseph D., Cortes, Jorge, Andreeff, Michael, Post, Sean M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709104/
https://www.ncbi.nlm.nih.gov/pubmed/28912176
http://dx.doi.org/10.3324/haematol.2017.168856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709104/
https://www.ncbi.nlm.nih.gov/pubmed/28912176
http://dx.doi.org/10.3324/haematol.2017.168856

Ejemplares similares